Belgium· BE-AMP-SAM532026-00

Zoladex Long Acting 10.8 mg

A goserelin product containing goserelin acetate, registered in Belgium by PI Pharma. The same ATC class is registered in 12 of our 19 countries.

ATC L02AE03

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about goserelin acetateAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Goserelin is registered in 12 of 19 countries.

Countries holding a registration under ATC L02AE03 (goserelin), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
8 of them publish a price we can compare per daily dose

Search goserelin products by name

Goserelin · ATC L02AE03

12 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of goserelin costs, country by country.

Normalised to the WHO defined daily dose (0.129 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Goserelin · price per daily dose (0.129 mg)

USD · FX 28 Sept 2026

CH Switzerland$5.39

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Goserelin Acetate
Manufacturer: PI Pharma
Country: Belgium (BE)
ATC code: L02AE03
ATC class: Goserelin
Defined daily dose: 0.129 mg, Implantat
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 2

be_apb
3872603
be_apb
7723786

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

461 interactions on record for goserelin.

Graded by severity as the source publishes them — 71 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check goserelin against other medicines How interaction checks work

Goserelin · interactions on record

461 records

71 severe
250 moderate
3 minor
137 info

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe
QuinidineC01BA01severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Goserelin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All goserelin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Zoladex Depot
Bulgaria · Золадекс, Золадекс Lа
Cyprus · Zoladex
Czechia · Reseligo, Zoladex Depot
Germany · Goserelin Endomedica, Gosgon
Denmark · Zoladex
Estonia · Reseligo, Zoladex
Spain · Zoladex, Zoladex Trimestral
Finland · Zoladex
France · Zoladex
United Kingdom (Northern Ireland) · Zoladex, Zoladex La
Greece · Implandex, Implandex La
Croatia · Reseligo, Zoladex
Hungary · Reseligo, Zildalis
Ireland · Zoladex, Zoladex La
Iceland · Reseligo, Zoladex
Italy · Zoladex
Lithuania · Algonad, Reseligo
Luxembourg · Zoladex, Zoladex Long Acting
Latvia · Reseligo
Malta · Golexin, Golexin La
Netherlands · Zoladex
Norway · Zoladex
Poland · Reseligo, Xanderla
Portugal · Golexin, Golexin La
Romania · Reseligo, Zoladex
Sweden · Zoladex
Slovenia · Reseligo, Zoladex
Slovakia · Reseligo, Zoladex Depot

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/dddaa6ef-5ec3-4bd7-9cb3-b32c9b22b4ca
GET /v1/drugs/dddaa6ef-5ec3-4bd7-9cb3-b32c9b22b4ca?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Implant",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Zoladex Long Acting 10.8 mg",
  "name_fr": "Zoladex Long Acting 10.8 mg",
  "name_nl": "Zoladex Long Acting 10.8 mg",
  "amp_code": "SAM532026-00",
  "strengths": [
    "10.8000",
    "10.8000"
  ],
  "pack_count": 1,
  "substances": [
    "Goserelin Acetate",
    "Goserelin"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Goserelin",
  "authorisation_numbers": [
    "1637PI0503F014"
  ]
}

API reference MCP server Plans

See everything about goserelin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console